Use of angiotensin-converting enzyme inhibitors after coronary artery bypass grafting in patients with diabetes mellitus.
Bistritz
Lana
L
Division of General Internal Medicine, University of Alberta Hospital, Edmonton, Canada.
Amad
Hani
H
Tandon
Puneeta
P
Man
Jeremy
J
Mullen
John C
JC
McAlister
Finlay A
FA
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000601:surgery*; D019983:Guideline Adherence; D006801:Humans; D008485:Medical Audit; D017410:Practice Guidelines as Topic; D017257:Ramipril / Q000008:administration & dosage / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D017257:Ramipril